Samah Abd Elhamid
About
In The Last Decade
Samah Abd Elhamid
25 papers receiving 510 citations
Peers
Comparison fields: 5 of 64
- Surgery 164
- Genetics 152
- Hepatology 139
- Molecular Biology 132
- Immunology 105
Countries citing papers authored by Samah Abd Elhamid
This map shows the geographic impact of Samah Abd Elhamid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samah Abd Elhamid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samah Abd Elhamid more than expected).
Fields of papers citing papers by Samah Abd Elhamid
This network shows the impact of papers produced by Samah Abd Elhamid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samah Abd Elhamid. The network helps show where Samah Abd Elhamid may publish in the future.
Co-authorship network of co-authors of Samah Abd Elhamid
This figure shows the co-authorship network connecting the top 25 collaborators of Samah Abd Elhamid. A scholar is included among the top collaborators of Samah Abd Elhamid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samah Abd Elhamid. Samah Abd Elhamid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 5 | |
| 4 | 21 | |
| 5 | 23 | |
| 6 | 5 | |
| 7 | 2 | |
| 8 | 12 | |
| 9 | 17 | |
| 10 | 26 | |
| 11 | 8 | |
| 12 | 3 | |
| 13 | 31 | |
| 14 | 82 | |
| 15 | 139 | |
| 16 | 14 | |
| 17 | 10 | |
| 18 | 12 | |
| 19 | Phase I Trial: Mesenchymal Stem Cells Transplantation in End Stage Liver Disease | 18 |
| 20 | 34 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.